{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:02:12Z","timestamp":1790283732843,"version":"4.1.0"},"reference-count":56,"publisher":"Japan Endocrine Society","issue":"1","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H03306"],"award-info":[{"award-number":["JP23H03306"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H03507"],"award-info":[{"award-number":["JP22H03507"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24764"],"award-info":[{"award-number":["23K24764"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K03060"],"award-info":[{"award-number":["25K03060"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23gm6910002"],"award-info":[{"award-number":["JP23gm6910002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJCR2123"],"award-info":[{"award-number":["JPMJCR2123"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0168","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:08:57Z","timestamp":1753913337000},"page":"13-20","source":"Crossref","is-referenced-by-count":2,"title":["Shifting cell death modes in hepatic steatosis: from apoptosis to necroptosis"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9757-9669","authenticated-orcid":false,"given":"Yuka","family":"Inaba","sequence":"first","affiliation":[{"name":"Metabolism and Nutrition Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Ishikawa 920-8640, Japan"},{"name":"Department of Physiology and Metabolism, Graduate School of Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-6920","authenticated-orcid":false,"given":"Kohsuke","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Division of Immunology and Molecular Biology, Cancer Research Institute, Kanazawa University, Ishikawa 920-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-6637","authenticated-orcid":false,"given":"Hiroshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Metabolism and Nutrition Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Ishikawa 920-8640, Japan"},{"name":"Department of Physiology and Metabolism, Graduate School of Medical Sciences, Kanazawa University, Ishikawa 920-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Taub R (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5: 836\u2013847.","DOI":"10.1038\/nrm1489"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Campana L, Esser H, Huch M, Forbes S (2021) Liver regeneration and inflammation: from fundamental science to clinical applications. Nat Rev Mol Cell Biol 22: 608\u2013624.","DOI":"10.1038\/s41580-021-00373-7"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Science 276: 60\u201366.","DOI":"10.1126\/science.276.5309.60"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Michalopoulos GK (2010) Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 176: 2\u201313.","DOI":"10.2353\/ajpath.2010.090675"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Abu Rmilah A, Zhou W, Nelson E, Lin L, Amiot B, et al. (2019) Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev Dev Biol 8: e340.","DOI":"10.1002\/wdev.340"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Michalopoulos GK, Bhushan B (2021) Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol 18: 40\u201355.","DOI":"10.1038\/s41575-020-0342-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Inaba Y, Furutani T, Kimura K, Watanabe H, Haga S, et al. (2015) Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice. Hepatology 61: 1343\u20131356.","DOI":"10.1002\/hep.27619"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Fuchs Y, Steller H (2015) Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nat Rev Mol Cell Biol 16: 329\u2013344.","DOI":"10.1038\/nrm3999"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Schwabe RF, Luedde T (2018) Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol 15: 738\u2013752.","DOI":"10.1038\/s41575-018-0065-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Zhu C, Tabas I, Schwabe RF, Pajvani UB (2021) Maladaptive regeneration\u2014the reawakening of developmental pathways in NASH and fibrosis. Nat Rev Gastroenterol Hepatol 18: 131\u2013142.","DOI":"10.1038\/s41575-020-00365-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Inaba Y, Hashiuchi E, Watanabe H, Kimura K, Oshima Y, et al. (2023) The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice. Nat Commun 14: 167.","DOI":"10.1038\/s41467-023-35804-w"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Wu X, Nagy LE, Gautheron J (2024) Mediators of necroptosis: from cell death to metabolic regulation. EMBO Mol Med 16: 219\u2013237.","DOI":"10.1038\/s44321-023-00011-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Luedde T, Kaplowitz N, Schwabe RF (2014) Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147: 765\u2013783.e764.","DOI":"10.1053\/j.gastro.2014.07.018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Afonso MB, David JC, Alves MI, Santos AA, Campino G, et al. (2024) Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: a narrative review. Metabolism 158: 155975.","DOI":"10.1016\/j.metabol.2024.155975"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kaplowitz N (2000) Mechanisms of liver cell injury. J Hepatol 32: 39\u201347.","DOI":"10.1016\/S0168-8278(00)80414-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Sundaram K, Mather AR, Marimuthu S, Shah PP, Snider AJ, et al. (2016) Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. Biochem J 473: 743\u2013755.","DOI":"10.1042\/BJ20150586"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Malhi H, Guicciardi ME, Gores GJ (2010) Hepatocyte death: a clear and present danger. Physiol Rev 90: 1165\u20131194.","DOI":"10.1152\/physrev.00061.2009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Elliott MR, Ravichandran KS (2016) The dynamics of apoptotic cell clearance. Dev Cell 38: 147\u2013160.","DOI":"10.1016\/j.devcel.2016.06.029"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Vandenabeele P, Bultynck G, Savvides SN (2023) Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat Rev Mol Cell Biol 24: 312\u2013333.","DOI":"10.1038\/s41580-022-00564-w"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Silva MT (2010) Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett 584: 4491\u20134499.","DOI":"10.1016\/j.febslet.2010.10.046"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Iurlaro R, Mu\u00f1oz-Pinedo C (2016) Cell death induced by endoplasmic reticulum stress. FEBS J 283: 2640\u20132652.","DOI":"10.1111\/febs.13598"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Li F, Huang Q, Chen J, Peng Y, Roop DR, et al. (2010) Apoptotic cells activate the \u201cphoenix rising\u201d pathway to promote wound healing and tissue regeneration. Sci Signal 3: ra13.","DOI":"10.1126\/scisignal.2000634"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, et al. (2004) Abnormal TNF activity in Timp3\u2013\/\u2013 mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969\u2013977.","DOI":"10.1038\/ng1413"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Bruccoleri A, Gallucci R, Germolec DR, Blackshear P, Simeonova P, et al. (1997) Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25: 133\u2013141.","DOI":"10.1053\/jhep.1997.v25.pm0008985279"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Haga S, Ozawa T, Yamada Y, Morita N, Nagashima I, et al. (2014) p62\/SQSTM1 plays a protective role in oxidative injury of steatotic liver in a mouse hepatectomy model. Antioxid Redox Signal 21: 2515\u20132530.","DOI":"10.1089\/ars.2013.5391"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, et al. (2009) Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50: 1072\u20131078.","DOI":"10.1002\/hep.23050"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27 Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, et al. (2003) Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437\u2013443.","DOI":"10.1016\/S0016-5085(03)00907-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ (2013) Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One 8: e70599.","DOI":"10.1371\/journal.pone.0070599"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Farrell GC, Larter CZ, Hou JY, Zhang RH, Yeh MM, et al. (2009) Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J Gastroenterol Hepatol 24: 443\u2013452.","DOI":"10.1111\/j.1440-1746.2009.05785.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Gautheron J, Vucur M, Reisinger F, Cardenas DV, Roderburg C, et al. (2014) A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis. EMBO Mol Med 6: 1062\u20131074.","DOI":"10.15252\/emmm.201403856"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, et al. (2001) Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 35: 568\u2013574.","DOI":"10.1016\/S0168-8278(01)00192-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD (2008) Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J Nutr 138: 1866\u20131871.","DOI":"10.1093\/jn\/138.10.1866"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, et al. (2015) The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int 35: 953\u2013966.","DOI":"10.1111\/liv.12570"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Harrison SA, Goodman Z, Jabbar A, Vemulapalli R, Younes ZH, et al. (2020) A randomized, placebo-controlled trial of emricasan in patients with NASH and F1\u2013F3 fibrosis. J Hepatol 72: 816\u2013827.","DOI":"10.1016\/j.jhep.2019.11.024"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Garcia-Tsao G, Bosch J, Kayali Z, Harrison SA, Abdelmalek MF, et al. (2020) Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension. J Hepatol 72: 885\u2013895.","DOI":"10.1016\/j.jhep.2019.12.010"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Gautheron J, Gores GJ, Rodrigues CMP (2020) Lytic cell death in metabolic liver disease. J Hepatol 73: 394\u2013408.","DOI":"10.1016\/j.jhep.2020.04.001"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Koren E, Fuchs Y (2021) Modes of regulated cell death in cancer. Cancer Discov 11: 245\u2013265.","DOI":"10.1158\/2159-8290.CD-20-0789"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38 Newton K, Dugger DL, Wickliffe KE, Kapoor N, de Almagro MC, et al. (2014) Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343: 1357\u20131360.","DOI":"10.1126\/science.1249361"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Petrie EJ, Hildebrand JM, Murphy JM (2017) Insane in the membrane: a structural perspective of MLKL function in necroptosis. Immunol Cell Biol 95: 152\u2013159.","DOI":"10.1038\/icb.2016.125"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Dara L, Liu ZX, Kaplowitz N (2016) Questions and controversies: the role of necroptosis in liver disease. Cell Death Discov 2: 16089.","DOI":"10.1038\/cddiscovery.2016.89"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Roychowdhury S, McCullough RL, Sanz-Garcia C, Saikia P, Alkhouri N, et al. (2016) Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury. Hepatology 64: 1518\u20131533.","DOI":"10.1002\/hep.28676"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Gautheron J, Vucur M, Schneider AT, Severi I, Roderburg C, et al. (2016) The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. Nat Commun 7: 11869.","DOI":"10.1038\/ncomms11869"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43 Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX, et al. (2013) Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58: 2099\u20132108.","DOI":"10.1002\/hep.26547"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44 Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE (2013) Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57: 1773\u20131783.","DOI":"10.1002\/hep.26200"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Saeed WK, Jun DW, Jang K, Oh JH, Chae YJ, et al. (2019) Decrease in fat <i>de novo<\/i> synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase. J Gastroenterol Hepatol 34: 2206\u20132218.","DOI":"10.1111\/jgh.14740"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Xu H, Du X, Liu G, Huang S, Du W, et al. (2019) The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation. Mol Metab 23: 14\u201323.","DOI":"10.1016\/j.molmet.2019.02.003"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Wu X, Poulsen KL, Sanz-Garcia C, Huang E, McMullen MR, et al. (2020) MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis. J Hepatol 73: 616\u2013627.","DOI":"10.1016\/j.jhep.2020.03.023"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, et al. (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11: 619\u2013633.","DOI":"10.1016\/S1097-2765(03)00105-9"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Tabas I, Ron D (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 13: 184\u2013190.","DOI":"10.1038\/ncb0311-184"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Lebeaupin C, Vall\u00e9e D, Hazari Y, Hetz C, Chevet E, et al. (2018) Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 69: 927\u2013947.","DOI":"10.1016\/j.jhep.2018.06.008"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Sano R, Reed JC (2013) ER stress-induced cell death mechanisms. Biochim Biophys Acta 1833: 3460\u20133470.","DOI":"10.1016\/j.bbamcr.2013.06.028"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Malhi H, Kaufman RJ (2011) Endoplasmic reticulum stress in liver disease. J Hepatol 54: 795\u2013809.","DOI":"10.1016\/j.jhep.2010.11.005"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, et al. (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12: 982\u2013995.","DOI":"10.1101\/gad.12.7.982"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Magne L, Blanc E, Legrand B, Lucas D, Barouki R, et al. (2011) ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes. J Hepatol 54: 729\u2013737.","DOI":"10.1016\/j.jhep.2010.07.023"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Uzi D, Barda L, Scaiewicz V, Mills M, Mueller T, et al. (2013) CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. J Hepatol 59: 495\u2013503.","DOI":"10.1016\/j.jhep.2013.04.024"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Tsai WW, Matsumura S, Liu W, Phillips NG, Sonntag T, et al. (2015) ATF3 mediates inhibitory effects of ethanol on hepatic gluconeogenesis. Proc Natl Acad Sci U S A 112: 2699\u20132704.","DOI":"10.1073\/pnas.1424641112"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/1\/73_EJ25-0168\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:41:48Z","timestamp":1768016508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/1\/73_EJ25-0168\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0168","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0168"}}